- Home
- CXW vs XENE Comparison
CXW vs XENE Comparison
Compare CXW & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXW
- XENE
- Stock Information
- Founded
- CXW 1983
- XENE 1996
- Country
- CXW United States
- XENE Canada
- Employees
- CXW N/A
- XENE N/A
- Industry
- CXW Real Estate Investment Trusts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- CXW Real Estate
- XENE Health Care
- Exchange
- CXW Nasdaq
- XENE Nasdaq
- Market Cap
- CXW 2.2B
- XENE 2.4B
- IPO Year
- CXW 1997
- XENE 2014
- Fundamental
- Price
- CXW $21.94
- XENE $32.21
- Analyst Decision
- CXW Strong Buy
- XENE Strong Buy
- Analyst Count
- CXW 3
- XENE 11
- Target Price
- CXW $32.67
- XENE $54.82
- AVG Volume (30 Days)
- CXW 977.7K
- XENE 1.5M
- Earning Date
- CXW 08-06-2025
- XENE 08-07-2025
- Dividend Yield
- CXW N/A
- XENE N/A
- EPS Growth
- CXW 36.58
- XENE N/A
- EPS
- CXW 0.77
- XENE N/A
- Revenue
- CXW $1,949,587,000.00
- XENE $7,500,000.00
- Revenue This Year
- CXW $5.27
- XENE N/A
- Revenue Next Year
- CXW $13.27
- XENE $253.71
- P/E Ratio
- CXW $28.68
- XENE N/A
- Revenue Growth
- CXW 0.53
- XENE N/A
- 52 Week Low
- CXW $11.82
- XENE $26.74
- 52 Week High
- CXW $24.99
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- CXW 55.86
- XENE 50.43
- Support Level
- CXW $21.63
- XENE $31.22
- Resistance Level
- CXW $22.40
- XENE $33.51
- Average True Range (ATR)
- CXW 0.64
- XENE 1.24
- MACD
- CXW 0.19
- XENE 0.06
- Stochastic Oscillator
- CXW 59.65
- XENE 40.88
About CXW CoreCivic Inc.
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.